SAR-125844 Uses, Dosage, Side Effects and more
SAR-125844 is under investigation in clinical trial NCT01391533 (Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors).
| Attribute | Details |
|---|---|
| Trade Name | SAR-125844 |
| Generic | SAR-125844 |
| Type | |
| Formula | C25H23FN8O2S2 |
| Weight | Average: 550.63 Monoisotopic: 550.136942524 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
